The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter

By sjmartinez • August 24, 2023

Butler J, Khan MS, Fonarow GC. The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter. J Am Coll Cardiol. 2023 Sep 5;82(10):1027-1029. doi: 10.1016/j.jacc.2023.06.007. Epub 2023 Aug 21. PMID: 37610399.

Tags: Cardiology/Epi, Clinical Trial, geographic region, heart failure, Publications, sodium-glucose co-transporter-2 inhibitors

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]

Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor[...]

Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis

Chen G, Chung T, Liu Z, Li YR, Scott K, Zhao X, Carol J, Park S, Zhou Y, Kim WJ, Ge X, Colby GP, Li[...]